Medical Condition News

RSS

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

A team of McMaster University researchers who studied heart patients found that stair-climbing routines, whether vigorous or moderate, provide significant cardiovascular and muscular benefits.

18 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Dendritic cells can take a shortcut to reach the lymph nodes more quickly

In its response to pathogens and vaccines, our immune system relies on dendritic cells. These white blood cells patrol the body's tissues, collect components of pathogens and vaccines and transport them via lymphatic vessels to the nearest lymph node.

18 May 2021

Abnormal blood levels of proteins linked to dementia, Alzheimer's disease

The development of dementia, often from Alzheimer's disease, late in life is associated with abnormal blood levels of dozens of proteins up to five years earlier, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health

18 May 2021

A potential treatment to prevent obesity-related liver damage

One of the especially dangerous health risks of being extremely overweight occurs when an obese person begins to accumulate fat in their liver.

18 May 2021

Pirfenidone significantly reduces a marker of heart muscle scarring

Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

Scientists at the University of Zurich have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics directly into tumor cells. Unlike chemotherapy or radiotherapy, this approach does no harm to normal healthy cells.

18 May 2021

Hyperinvasive approach is an effective treatment strategy for out-of-hospital cardiac arrest

A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to standard advanced cardiac life support (ACLS), were immediately transported to a cardiac care center, and placed on a device similar to a heart-lung bypass machine were more likely to have survived with good brain function six months later than similar patients who received standard care at the site where the OHCA occurred.

18 May 2021

New review questions the validity of research on the impact of screen time on mental health

University researchers have carried out the largest systematic review and meta-analysis to date of how people's perceptions of their screen time compare with what they do in practice, finding estimates of usage were only accurate in about five per cent of studies.

18 May 2021

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease.

18 May 2021

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

MUSC Hollings Cancer Center lung cancer researcher Gerard Silvestri, M.D., found that a lack of insurance leads to worse cancer survival than for those with Medicare, in a paper published in the May issue of Health Affairs.

17 May 2021

New cardiac rehabilitation intervention improves quality of life in hospitalized heart failure patients

An innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life, and depression in hospitalized heart failure patients, compared to traditional rehabilitation programs.

17 May 2021

Study raises more concerns about the use of combined EPA/DHA through supplements

Doctors often recommend Omega-3s to help patients lower their cholesterol and improve heart health. Those Omega-3s can come from fatty fish like salmon and mackerel, or supplements that often contain a combination of the acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

17 May 2021

Long-term prescription medication use may not improve disturbed sleep

Long term use of prescription meds for insomnia doesn’t seem to improve disturbed sleep in middle-aged women, suggests research published in the online journal BMJ Open.

17 May 2021

Scientists initiate a groundbreaking project to treat stroke once and for all

A leading group of scientists working in universities, research centers, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all.

17 May 2021

Study highlights the need for more personalized approach to measuring BMI

The results of an extensive new study funded by the National Institute for Health Research (NIHR), Ethnic-specific BMI cut-off points for obesity based on type 2 diabetes mellitus risk: a cohort study of 1.5 million people in England, presented at this year’s European Congress on Obesity (ECO) and published simultaneously in the leading journal, The Lancet Diabetes & Endocrinology reveal that inaccurate and outdated interpretations of the standard Body Mass Index (BMI) values for patients from BAME backgrounds in England could potentially be putting their health at risk.

17 May 2021

Simple surgery saves patients with heart arrhythmia caused by often-lethal strokes

A simple surgery saves patients with heart arrhythmia from often-lethal strokes, says a large international study led by McMaster University.

17 May 2021

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral artery disease (PAD) who underwent lower extremity revascularization, a procedure to open blocked arteries in the leg.

17 May 2021

Survey: 40% of people with liver disease have been worried about mental health impact of the pandemic

A survey by the British Liver Trust in March 2021 has revealed that 40% of people with liver disease have been worried about their mental health during the pandemic.

17 May 2021

Medical Condition News

Stair-climbing routines provide cardiovascular and muscular benefits to heart patients

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Dendritic cells can take a shortcut to reach the lymph nodes more quickly

Abnormal blood levels of proteins linked to dementia, Alzheimer's disease

A potential treatment to prevent obesity-related liver damage

Pirfenidone significantly reduces a marker of heart muscle scarring

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

Hyperinvasive approach is an effective treatment strategy for out-of-hospital cardiac arrest

New review questions the validity of research on the impact of screen time on mental health

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

New cardiac rehabilitation intervention improves quality of life in hospitalized heart failure patients

Study raises more concerns about the use of combined EPA/DHA through supplements

Long-term prescription medication use may not improve disturbed sleep

Scientists initiate a groundbreaking project to treat stroke once and for all

Study highlights the need for more personalized approach to measuring BMI

Simple surgery saves patients with heart arrhythmia caused by often-lethal strokes

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Survey: 40% of people with liver disease have been worried about mental health impact of the pandemic

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News